X-3612334-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_005044.5(PRKX):c.952-9G>A variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0026 in 1,204,527 control chromosomes in the GnomAD database, including 4 homozygotes. There are 999 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0018 ( 0 hom., 44 hem., cov: 22)
Exomes 𝑓: 0.0027 ( 4 hom. 955 hem. )
Consequence
PRKX
NM_005044.5 splice_polypyrimidine_tract, intron
NM_005044.5 splice_polypyrimidine_tract, intron
Scores
2
Splicing: ADA: 0.00008753
2
Clinical Significance
Conservation
PhyloP100: -1.64
Genes affected
PRKX (HGNC:9441): (protein kinase cAMP-dependent X-linked catalytic subunit) This gene encodes a serine threonine protein kinase that has similarity to the catalytic subunit of cyclic AMP dependent protein kinases. The encoded protein is developmentally regulated and may be involved in renal epithelial morphogenesis. This protein may also be involved in macrophage and granulocyte maturation. Abnormal recombination between this gene and a related pseudogene on chromosome Y is a frequent cause of sex reversal disorder in XX males and XY females. Pseudogenes of this gene are found on chromosomes X, 15 and Y. [provided by RefSeq, Feb 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BP6
Variant X-3612334-C-T is Benign according to our data. Variant chrX-3612334-C-T is described in ClinVar as [Benign]. Clinvar id is 784728.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Hemizygotes in GnomAd4 at 44 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PRKX | NM_005044.5 | c.952-9G>A | splice_polypyrimidine_tract_variant, intron_variant | ENST00000262848.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PRKX | ENST00000262848.6 | c.952-9G>A | splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_005044.5 | P1 | |||
PRKX | ENST00000425240.1 | n.654-9G>A | splice_polypyrimidine_tract_variant, intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.00181 AC: 201AN: 110888Hom.: 0 Cov.: 22 AF XY: 0.00133 AC XY: 44AN XY: 33102
GnomAD3 genomes
AF:
AC:
201
AN:
110888
Hom.:
Cov.:
22
AF XY:
AC XY:
44
AN XY:
33102
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00176 AC: 307AN: 174571Hom.: 0 AF XY: 0.00164 AC XY: 98AN XY: 59627
GnomAD3 exomes
AF:
AC:
307
AN:
174571
Hom.:
AF XY:
AC XY:
98
AN XY:
59627
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00268 AC: 2927AN: 1093583Hom.: 4 Cov.: 30 AF XY: 0.00266 AC XY: 955AN XY: 359263
GnomAD4 exome
AF:
AC:
2927
AN:
1093583
Hom.:
Cov.:
30
AF XY:
AC XY:
955
AN XY:
359263
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00181 AC: 201AN: 110944Hom.: 0 Cov.: 22 AF XY: 0.00133 AC XY: 44AN XY: 33168
GnomAD4 genome
AF:
AC:
201
AN:
110944
Hom.:
Cov.:
22
AF XY:
AC XY:
44
AN XY:
33168
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 06, 2017 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at